Senesco Technologies (ELOX)
(Delayed Data from OTC)
$0.00 USD
-0.69 (-99.91%)
Updated Sep 19, 2024 09:37 AM ET
NA Value
NA Growth NA Momentum NA VGMPrice, Consensus and EPS Surprise
ELOX 0.00 -0.69(-99.91%)
Will ELOX be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for ELOX based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for ELOX
Senesco Technologies Inc. (ELOX) Reports Q1 Loss, Lags Revenue Estimates
Are Medical Stocks Lagging Elevation Oncology (ELEV) This Year?
ELOX: What are Zacks experts saying now?
Zacks Private Portfolio Services
Senesco Technologies Inc. (ELOX) Could Find a Support Soon, Here's Why You Should Buy the Stock Now
Biotech Stock Roundup: GILD, BMY's Regulatory News, BLUE's Therapy Approval & More
Eloxx (ELOX) Down After Cystic Fibrosis Study Fails to Meet Goal
Other News for ELOX
Eloxx Pharmaceuticals Provides Pipeline and Financing Updates